Solubilization of α-galactosylceramide in aqueous medium: Impact on Natural Killer T cell activation and antitumor responses

被引:9
|
作者
Macho-Fernandez, Elodie [1 ,2 ,3 ,4 ,5 ]
Chekkat, Neila [6 ]
Ehret, Christophe [6 ]
Thomann, Jean-Sebastien [6 ]
De Giorgi, Marcella [6 ]
Spanedda, Maria Vittoria [6 ]
Bourel-Bonnet, Line [6 ]
Betbeder, Didier [7 ,8 ]
Heurtault, Beatrice [6 ]
Faveeuw, Christelle [1 ,2 ,3 ,4 ,5 ]
Fournel, Sylvie [6 ]
Frisch, Benoit [6 ]
Trottein, Francois [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Lille, CIIL, U1019, UMR 8204, F-59000 Lille, France
[2] CNRS, UMR 8204, F-59000 Lille, France
[3] INSERM, U1019, F-59000 Lille, France
[4] CHU Lille, F-59000 Lille, France
[5] Inst Pasteur, F-59000 Lille, France
[6] Univ Strasbourg, CNRS, CAMB UMR 7199, F-67000 Strasbourg, France
[7] Univ Lille 2, CHRU Lille, INSERM, LIRIC,UMR 995, F-59045 Lille, France
[8] Univ Artois, F-62000 Arras, France
关键词
iNKT; alpha-GalCer formulations; Liposomes; Micelles; Water-soluble alpha-GalCer; Cancer; V-ALPHA-24-INVARIANT NKT CELLS; LUNG-CANCER PATIENTS; DENDRITIC CELLS; ANTIGEN PRESENTATION; VACCINE ADJUVANTS; PHASE-I; IMMUNITY; DELIVERY; INNATE; LIPOSOMES;
D O I
10.1016/j.ijpharm.2017.07.054
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The potent antitumor effect of alpha-galactosylceramide (alpha-GalCer) is based on its recognition by invariant Natural Killer T cells (iNKT) after its capture and presentation by antigen presenting cells including dendritic cells (DCs). Synthetic alpha-GalCer has already been tested in advanced cancer patients but no or only moderate clinical responses were obtained. To optimize alpha-GalCer efficacy, we have postulated that alternative formulations impacting its molecular organization in aqueous medium could modify DC uptake and iNKT-based immune responses. To this end, we have developed two strategies: (1) the formulation of alpha-GalCer in non-cationic liposomes and (2) the synthesis of a water-soluble alpha-GalCer analogue by anchoring a polyethyleneglycol moiety on its sugar head. The biological activities of these new preparations were compared to that induced by the classically used Polysorbate 20 alpha-GalCer micelles. Both formulations retained their uptake by DCs and activated iNKT cells both in vitro and in vivo. Despite a lower cytokine production, the formulations induced a potent immune response able to control lung murine carcinoma. In conclusion, it is possible to increase alpha-GalCer solubility in aqueous solution without limiting its antitumor properties. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:354 / 363
页数:10
相关论文
共 50 条
  • [31] Mantle cell lymphoma associated sphingosine-1 phosphate inhibits natural killer T cell mediated antitumor responses
    Webb, Tonya
    Kimball, Amy
    Sun, Wenji
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [32] Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
    Sharif, S
    Arreaza, GA
    Zucker, P
    Mi, QS
    Sharif, S
    Arreaza, GA
    Zucker, P
    Mi, QS
    Sondhi, J
    Naidenko, OV
    Kronenberg, M
    Koezuka, Y
    Delovitch, TL
    Gombert, JM
    Leite-De-Moraes, M
    Gouarin, C
    Zhu, R
    Hameg, A
    Nakayama, T
    Taniguchi, M
    Lepault, F
    Lehuen, A
    Bach, JF
    Herbelin, A
    NATURE MEDICINE, 2001, 7 (09) : 1057 - 1062
  • [33] The natural killer T cell ligand α-galactosylceramide prevents or promotes pristane-induced lupus in mice
    Singh, AK
    Yang, JQ
    Parekh, VV
    Wei, J
    Wang, CR
    Joyce, S
    Singh, RR
    Van Kaer, L
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (04) : 1143 - 1154
  • [34] Attenuation of invariant Natural Killer T-cell anergy induction through intradermal delivery of α-galactosylceramide
    Bontkes, Hetty J.
    Moreno, Maria
    Hangalapura, Basav
    Lindenberg, Jelle J.
    de Groot, Jan
    Lougheed, Sinead
    van der Vliet, Hans J. J.
    van den Eertwegh, Alfons J. M.
    de Gruijl, Tanja D.
    von Blomberg, B. Mary E.
    Scheper, Rik J.
    CLINICAL IMMUNOLOGY, 2010, 136 (03) : 364 - 374
  • [35] Natural killer cells regulate diverse T cell responses
    Crome, Sarah Q.
    Lang, Philipp A.
    Lang, Karl S.
    Ohashi, Pamela S.
    TRENDS IN IMMUNOLOGY, 2013, 34 (07) : 342 - 349
  • [36] Effect of Hyperlipidemia on Natural Killer T-Cell Activation
    Braun, Nicole A.
    Major, Amy S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E13 - E13
  • [37] Effect of natural killer T cell activation on the initiation of atherosclerosis
    van Puijvelde, Gijs H. M.
    van Wanrooij, Eva J. A.
    Hauer, Arnaud D.
    de Vos, Paula
    van Berkel, Theo J. C.
    Kuiper, Johan
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) : 223 - 230
  • [38] IFN-γ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide
    Hayakawa, Y
    Takeda, K
    Yagita, H
    Smyth, MJ
    Van Kaer, L
    Okumura, K
    Saiki, I
    BLOOD, 2002, 100 (05) : 1728 - 1733
  • [39] Cross Talk Between Natural Killer T and Dendritic Cells and Its Impact on T Cell Responses in Infections
    Zhao, Lei
    Yang, Xi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] Natural killer (NK)-T cell activation by a-galactosylceramide in the presence of CD1d provides protection against colitis.
    Saubermann, LJ
    Beck, P
    de Jong, YP
    Pitman, RS
    Terhorst, C
    Exley, M
    Snapper, SB
    Balk, SP
    Hagen, SJ
    Podolsky, DK
    Koezuka, Y
    Blumberg, RS
    GASTROENTEROLOGY, 2000, 118 (04) : A189 - A189